Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gullaksen SE"'
Autor:
Ha TQ; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway., Andresen V; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Erikstein BS; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway., Popa M; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; KinN Therapeutics AS, Bergen, Norway., Gullaksen SE; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Reikvam H; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Leukemia Research Group, Department of Clinical Science, University of Bergen, Bergen, Norway., McCormack E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Nov 24. Date of Electronic Publication: 2024 Nov 24.
Autor:
Sefland Ø; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Gullaksen SE; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Omsland M; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Safety, Chemistry, and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway., Reikvam H; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Galteland E; Department of Haematology, Oslo University Hospital, Oslo, Norway., Tran HTT; Department of Haematology, Akershus University Hospital, Lørenskog, Norway., Spetalen S; Department of Pathology, Oslo University Hospital, Oslo, Norway., Singh SK; Mendus A.B., Stockholm, Sweden., Van Zeeburg HJT; Mendus A.B., Stockholm, Sweden., Van De Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul 30. Date of Electronic Publication: 2024 Jul 30.
Autor:
Kleftogiannnis D; Department of Informatics, Computational Biology Unit, University of Bergen, 5020 Bergen, Norway.; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Neuro-SysMed Centre of Clinical Treatment Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Gavasso S; Neuro-SysMed Centre of Clinical Treatment Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Tislevoll BS; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., van der Meer N; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, 9713 Groningen, the Netherlands., Motzfeldt IKF; Department of Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, 5021 Bergen, Norway., Hellesøy M; Department of Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, 5021 Bergen, Norway., Gullaksen SE; Department of Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, 5021 Bergen, Norway., Griessinger E; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, 9713 Groningen, the Netherlands., Fagerholt O; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Lenartova A; Department of Hematology, Oslo University Hospital, 4950 Oslo, Norway., Fløisand Y; Department of Hematology, Oslo University Hospital, 4950 Oslo, Norway., Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, 9713 Groningen, the Netherlands., Gjertsen BT; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, 5021 Bergen, Norway., Jonassen I; Department of Informatics, Computational Biology Unit, University of Bergen, 5020 Bergen, Norway.; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.
Publikováno v:
IScience [iScience] 2024 Jun 12; Vol. 27 (7), pp. 110261. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).
Autor:
Thomsen LCV; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway.; Norwegian Institute of Public Health, 5015 Bergen, Norway., Kleinmanns K; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Anandan S; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway., Gullaksen SE; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Abdelaal T; Delft Bioinformatics Laboratory, Delft University of Technology, 2628XE Delft, The Netherlands.; Department of Radiology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands., Iversen GA; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway., Akslen LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway.; Department of Pathology, Haukeland University Hospital, 5021 Bergen, Norway., McCormack E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Bjørge L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Oct 23; Vol. 15 (20). Date of Electronic Publication: 2023 Oct 23.
Autor:
Rim S; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway., Sakkestad ST; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway., Zhou F; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway., Gullaksen SE; Department of Clinical Science, Centre of Cancer Biomarkers (CCBIO), University of Bergen, Bergen, Norway.; Hematology Section, Department of Internal Medicine, Helse Bergen, Bergen, Norway., Skavland J; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway., Chauhan SK; Division of Cancer Medicine, Department of Cancer Immunology, Oslo University Hospital, Oslo, Norway., Steinsland H; Department of Global Public Health and Primary Care, Faculty of Medicine, Centre for Intervention Science in Maternal and Child Health (CISMAC), Centre for International Health, University of Bergen, Bergen, Norway.; Department of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway., Hanevik K; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Medicine, Norwegian National Advisory Unit on Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
European journal of immunology [Eur J Immunol] 2023 Aug; Vol. 53 (8), pp. e2250254. Date of Electronic Publication: 2023 Jun 28.
Autor:
Geelen IGP; Department of Internal Medicine / Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands. i.geelen@erasmusmc.nl., Gullaksen SE; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Internal Medicine, Hematology section, Helse Bergen, Bergen, Norway., Ilander MM; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer center, Helsinki, Finland., Olssen-Strömberg U; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Richter J; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Blijlevens NMA; Department of Hematology, Radboud UMC, Nijmegen, The Netherlands., Smit WM; Department of Hematology, Medical Spectrum Twente, Enschede, The Netherlands., Gjertsen BT; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Internal Medicine, Hematology section, Helse Bergen, Bergen, Norway., Gedde-Dahl T; Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Markevärn B; Department of Hematology, Umeå University Hospital, Umeå, Sweden., Koppes MMA; Department of Hematology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands., Westerweel PE; Department of Internal Medicine / Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Hjorth-Hansen H; Department of Hematology, St Olavs Hospital, Trondheim, Norway.; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Janssen JJWM; Department of Hematology, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Jun; Vol. 102 (6), pp. 1395-1408. Date of Electronic Publication: 2023 Apr 29.
Autor:
Tislevoll BS; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Hellesøy M; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Fagerholt OHE; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Gullaksen SE; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Srivastava A; Genome Core Facility, Clinical Laboratory, K2 Haukeland University Hospital, Bergen, Norway., Birkeland E; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, Bergen, Norway., Kleftogiannis D; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway., Piechaczyk L; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Tadele DS; Department of Molecular Genetics, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, 44106, USA., Skavland J; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Hovland R; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway., Andresen V; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Seternes OM; Department of Pharmacy, UiT-The Arctic University of Norway, 9037, Tromsø, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway., Aghaeepour N; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Biomedical Informatics, Stanford University School of Medicine, Stanford, CA, 94121, USA., Gavasso S; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Clinical Treatment Research (NeuroSysMed), Department of Clinical Science, University of Bergen, Bergen, Norway., Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jonassen I; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Fløisand Y; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway., Enserink J; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, 0037, Oslo, Norway., Blaser N; Department of Informatics, University of Bergen, Bergen, Norway. nello.blaser@uib.no., Gjertsen BT; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.gjertsen@uib.no.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway. bjorn.gjertsen@uib.no.
Publikováno v:
Nature communications [Nat Commun] 2023 Mar 30; Vol. 14 (1), pp. 1767. Date of Electronic Publication: 2023 Mar 30.
Autor:
Tislevoll BS; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Hellesøy M; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Fagerholt OHE; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Gullaksen SE; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Srivastava A; Genome Core Facility, Clinical Laboratory, K2 Haukeland University Hospital, Bergen, Norway., Birkeland E; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, Bergen, Norway., Kleftogiannis D; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway., Piechaczyk L; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Tadele DS; Department of Molecular Genetics, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, 44106, USA., Skavland J; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Hovland R; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway., Andresen V; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Seternes OM; Department of Pharmacy, UiT-The Arctic University of Norway, 9037, Tromsø, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway., Aghaeepour N; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Biomedical Informatics, Stanford University School of Medicine, Stanford, CA, 94121, USA., Gavasso S; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Clinical Treatment Research (NeuroSysMed), Department of Clinical Science, University of Bergen, Bergen, Norway., Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jonassen I; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Fløisand Y; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway., Enserink J; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, 0037, Oslo, Norway., Blaser N; Department of Informatics, University of Bergen, Bergen, Norway. nello.blaser@uib.no., Gjertsen BT; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.gjertsen@uib.no.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway. bjorn.gjertsen@uib.no.
Publikováno v:
Nature communications [Nat Commun] 2023 Jan 07; Vol. 14 (1), pp. 115. Date of Electronic Publication: 2023 Jan 07.
Autor:
Kleinmanns K; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway., Gullaksen SE; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway., Bredholt G; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway., Davidson B; Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, 0310 Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway., Torkildsen CF; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway.; Department of Obstetrics and Gynecology, Stavanger University Hospital, 4011 Stavanger, Norway., Grindheim S; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway., Bjørge L; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway., McCormack E; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, 5020 Bergen, Norway.; Vivarium, Department of Clinical Science, University of Bergen, Jonas Lies vei 65, 5021 Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, The University of Bergen, Jonas Lies vei 65, 5021 Bergen, Norway.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jun 23; Vol. 14 (13). Date of Electronic Publication: 2022 Jun 23.
Autor:
Anandan S; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway., Thomsen LCV; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway., Gullaksen SE; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Abdelaal T; Delft Bioinformatics Lab, Delft University of Technology, 2600 AA Delft, The Netherlands., Kleinmanns K; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Skavland J; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Bredholt G; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Gjertsen BT; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, 5021 Bergen, Norway., McCormack E; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, The University of Bergen, Jonas Lies vei 65, 5021 Bergen, Norway., Bjørge L; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, 5021 Bergen, Norway.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Feb 11; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 11.